Systemic and local saphenous vein graft thrombolysis using a tissue plasminogen activator

Catheterization and Cardiovascular Diagnosis
M H SalingerR D Stagl

Abstract

Many studies are currently evaluating the potential role of thrombolytic therapy in patients with ischemic syndromes who have undergone previous coronary artery bypass grafting. Limited experience has been published regarding the use of local urokinase and streptokinase infusions and the use of systemic recombinant tissue-type plasminogen activator as thrombolytic agents in patients with previous coronary artery bypass surgery. To date, however, there has been no published experience regarding the use of recombinant tissue-type plasminogen activator (rt-PA) either systemically or locally in the post-bypass patient where angiographic demonstration of aortocoronary saphenous vein graft obstruction was available pre- and post-therapy. Similarly there has been no previous report of the use of rt-PA infused locally to recanalize an occluded aortocoronary saphenous vein graft. This report describes successful thrombolysis and subsequent balloon angioplasty of saphenous vein grafts with angiographically documented thrombus using systemic and local rt-PA infusion.

Citations

Jan 1, 1993·Catheterization and Cardiovascular Diagnosis·J C BlankenshipN P Madigan
May 1, 1993·Catheterization and Cardiovascular Diagnosis·J T EaganR R Heuser
Oct 1, 1993·Catheterization and Cardiovascular Diagnosis·L BilodeauG S Roubin
Jun 1, 1992·Chest·A J Tiefenbrunn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.